SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-029141
Filing Date
2022-08-11
Accepted
2022-08-11 16:33:41
Documents
65
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pstx-10q_20220630.htm   iXBRL 10-Q 2536795
2 EX-10.1 pstx-ex101_369.htm EX-10.1 34477
3 EX-31.1 pstx-ex311_7.htm EX-31.1 19071
4 EX-31.2 pstx-ex312_9.htm EX-31.2 19090
5 EX-32.1 pstx-ex321_6.htm EX-32.1 7820
6 EX-32.2 pstx-ex322_8.htm EX-32.2 7838
  Complete submission text file 0001564590-22-029141.txt   7873920

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA pstx-20220630.xsd EX-101.SCH 52541
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pstx-20220630_cal.xml EX-101.CAL 48557
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pstx-20220630_def.xml EX-101.DEF 190929
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pstx-20220630_lab.xml EX-101.LAB 448234
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pstx-20220630_pre.xml EX-101.PRE 329233
59 EXTRACTED XBRL INSTANCE DOCUMENT pstx-10q_20220630_htm.xml XML 1126741
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Filer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39376 | Film No.: 221156425
SIC: 2836 Biological Products, (No Diagnostic Substances)